At-Home Hormone Tests for Perimenopause: FSH, LH, Estrogen Kits Compared 2026
The default response to early perimenopause symptoms has long been the same: wait and see, then schedule a clinic visit. But a growing segment of women between their late 30s and early 50s are choosing a different first step. They’re testing their own hormones at home.
Yahoo Health’s 2026 roundup of the best menopause test kits evaluated six products through real-world use. Four stand out as genuinely useful, though each comes with a different set of tradeoffs. Here’s what they measure, what they cost, and what the numbers actually mean.
Why Hormone Testing Matters in Perimenopause
Perimenopause is not a single moment. It’s a transitional phase that typically spans four to seven years before the final menstrual period, marked by increasingly erratic estrogen and progesterone production. As ovarian function declines, the pituitary gland pushes out more FSH (follicle-stimulating hormone) and LH (luteinizing hormone) to compensate.
A blood FSH level consistently above 25 IU/L alongside irregular cycles is a recognized clinical signal of perimenopause. The problem is that FSH swings dramatically across a single cycle, making any one measurement unreliable on its own. That’s the gap at-home testing is trying to fill: a way to observe patterns over time, without a clinic appointment every time you want data.
Four Kits Compared
| Product | Method | Hormones Tested | Price (US) | Key Feature |
|---|---|---|---|---|
| Clearblue Menopause Stage Estimator (5-pack) | Urine | FSH | $19.98 | 10-day, 5-test protocol |
| Mira Hormone Monitor (Clarity Kit) | Urine | FSH, LH, E3G, PdG | Device required (~$199+) | Lab-grade optical reader, app tracking |
| Labcorp OnDemand Menopause Test | Blood (self-collected, mail-in) | FSH, LH, estradiol, progesterone | $139 | Clinical-grade blood panel, no clinic visit |
| Quest Health Menopause Assessment | Blood (in-person draw) | FSH, LH, estradiol | $155 | Phlebotomist draw at Quest location |
Clearblue Menopause Stage Estimator, $19.98
The lowest-cost entry point in the category. You test your urine on at least five occasions spread across a 10-day window, and the app analyzes the FSH pattern rather than flagging a single number. The FDA has cleared Clearblue’s OTC menopause testing products, which puts it in a small group of formally reviewed kits.
What it won’t show: LH, estradiol, or progesterone. FSH alone gives a partial picture, and urine-based measurement captures a metabolite rather than the serum value clinicians use for diagnosis. It works best as a first-pass screen.
Mira Hormone Monitor (Clarity Kit)
Mira sells a reusable optical reader device (typically $199 to $299) and proprietary test wands. The device analyzes the wand photometrically and syncs results to an app. It measures four hormones: FSH, LH, E3G (estrone-3-glucuronide, an estrogen metabolite), and PdG (pregnanediol glucuronide, a progesterone metabolite).
The multi-hormone view across the full cycle is Mira’s distinguishing feature. For women who want to track hormonal shifts month over month, the cumulative data becomes increasingly useful. The ongoing cost of wand refills and the learning curve of the interface are the main friction points.
Labcorp OnDemand Menopause Test, $139
A fingerstick blood sample collected at home, mailed to a Labcorp facility, and processed using the same methods as clinical labs. Results include FSH, LH, estradiol, and progesterone, giving the most complete hormonal picture of the four options.
Blood-based measurement removes the approximation built into urine metabolite testing. For women who want data they can share directly with a physician in a clinical context, this is the closest match to what a clinic would order. The self-collection process requires following the instructions carefully, but for most people it’s straightforward.
Quest Health Menopause Assessment, $155
Similar blood panel to Labcorp, but you visit a Quest Diagnostics patient service center for a standard venipuncture draw by a phlebotomist. If self-collection feels like a barrier, Quest removes it. Coverage is limited to areas with Quest locations.
What Urine Testing Can and Cannot Show
Most at-home kits measure hormone metabolites in urine, not the hormones themselves. Estradiol converts to E3G; progesterone converts to PdG. These metabolites track directionally with serum hormone levels, but the numbers are not equivalent.
Clinical guidelines reference serum estradiol (E2) and serum FSH, not urine metabolites. Studies on urine FSH test accuracy report approximately 90% sensitivity, a meaningful margin for a screening tool, but also one that leaves room for false positives (appearing elevated when levels are normal) and false negatives (appearing normal when the transition has begun). The majority of commercially sold at-home FSH kits do not carry FDA approval, a distinction worth understanding before treating results as clinical findings.
The Single-Reading Problem
FSH is highest in the follicular phase of the cycle, particularly just before ovulation when LH surges. In perimenopause, these peaks become less predictable and the baseline creeps upward, but can still drop back into a premenopausal range day to day. A reading that looks elevated on Tuesday can look normal by Friday.
This is why Clearblue’s protocol calls for five readings and why Mira’s value increases the longer it’s used. A pattern across multiple cycles is diagnostically meaningful. A single reading, whether high or normal, is not.
Using These Tests With Your Doctor
At-home hormone tests are preparation tools, not replacements for clinical evaluation. The most effective use is building a data record before a gynecology appointment: screenshots from the Mira app, printed Clearblue charts, or the PDF results from Labcorp.
That data gives a clinician context. Instead of reconstructing symptoms from memory, you’re handing over a timeline. A physician will then order confirmatory serum testing, evaluate the results alongside symptom history and physical findings, and make a clinical determination. If your at-home results appear normal but symptoms persist, such as disrupted sleep, irregular cycles, or vasomotor episodes, that is reason to see a doctor regardless of what the kit showed.
The shift happening in this space isn’t about bypassing medical care. It’s about arriving at the appointment with better questions and more specific information. That’s a meaningful change.